259 related articles for article (PubMed ID: 20633534)
1. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC
J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413
[TBL] [Abstract][Full Text] [Related]
3. A novel role of angiopoietin-like-3 associated with podocyte injury.
Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H
Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887
[TBL] [Abstract][Full Text] [Related]
4. [Dexamethasone Blocks Adriamycin-induced Podocytes'Mobility via Impacting Nephrin Expression].
Qiu B; Gao X; Cui WJ; Lei XY; Niu CH; Liu HJ; Zhang M; Liu QJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):197-202. PubMed ID: 31106539
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy.
Doublier S; Zennaro C; Spatola T; Lupia E; Bottelli A; Deregibus MC; Carraro M; Conaldi PG; Camussi G
AIDS; 2007 Feb; 21(4):423-32. PubMed ID: 17301560
[TBL] [Abstract][Full Text] [Related]
6. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
7. A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro.
Dai R; Lin Y; Liu H; Rao J; Zhai Y; Zha X; Fang X; Xu H
BMC Nephrol; 2015 Mar; 16():38. PubMed ID: 25884163
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
9. Nephrin-signature molecule of the glomerular podocyte?
Welsh GI; Saleem MA
J Pathol; 2010 Feb; 220(3):328-37. PubMed ID: 19950250
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiopoietin-like 3 associated with puromycin-induced podocyte damage.
Jia R; Hong X; Li S; Haichun Y; Chuanming H
Nephron Exp Nephrol; 2010; 115(3):e38-45. PubMed ID: 20424482
[TBL] [Abstract][Full Text] [Related]
11. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CD2-associated protein impaired the physiological functions of podocytes.
Zhang C; Jiang HJ; Chang Y; Fang Z; Sun XF; Liu JS; Deng AG; Zhu ZH
Cell Biol Int; 2009 Jun; 33(6):632-9. PubMed ID: 19306938
[TBL] [Abstract][Full Text] [Related]
14. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
Bondeva T; Wojciech S; Wolf G
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098
[TBL] [Abstract][Full Text] [Related]
16. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.
Collino F; Bussolati B; Gerbaudo E; Marozio L; Pelissetto S; Benedetto C; Camussi G
Am J Physiol Renal Physiol; 2008 May; 294(5):F1185-94. PubMed ID: 18287402
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
18. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
[TBL] [Abstract][Full Text] [Related]
19. Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases.
Ikezumi Y; Suzuki T; Karasawa T; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
Biochem Biophys Res Commun; 2008 Nov; 376(4):706-11. PubMed ID: 18809387
[TBL] [Abstract][Full Text] [Related]
20. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
